Fortis Healthcare Limited has informed the Exchange about General Updates
FORTIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Fortis Healthcare informed the exchanges about two changes in its Board composition, both effective from the close of business hours on June 27, 2025. Mr. Mehmet Ali Aydinlar, a Non-Executive & Non-Independent Director, resigned citing other commitments and responsibilities. Ms. Shailaja Chandra, a Non-Executive & Independent Director, stepped down at the end of her term and will also exit all Board Committee roles. The company has filed the required detailed disclosures under SEBI Listing Regulations (Regulation 30) along with the resignation letter.
These are routine board-level changes with no direct impact on the company's operations, financials, or business strategy. Shareholders may want to monitor whether the company announces replacements soon, particularly for the independent director seat, as it affects board composition and committee oversight.